Becton, Dickinson and Company

BDX Healthcare Medical Instruments & Supplies

Becton, Dickinson and Company’s revenue for fiscal 2025 (year ended September 2025) was $21.8 billion, up 8.24% from fiscal 2024.

Revenue
−9.55%
EPS
−31.5%
Free cash flow
−31.6%
Total debt
−22.9%

Quarter to June 2026, against a year earlier

212.96 3.77 +1.80%
Market cap
$58.2B
P/E
64.1×
Fwd P/E
39.2×
Dividend yield
1.87%
F-score
7/9
Altman Z
1.85
Beneish M
−2.64
Dividend safety
67/100
Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 Sep '19 Sep '18 Sep '17 Sep '16
P/E ratio
25.65 32.43 41.34 30.13 27.89 66.33 50.08 422.98 32.26 30.03
Piotroski F-Score
7 6 5 5 7 5 7 4 5 —
Altman Z-Score
1.85 1.99 2.27 2.01 2.01 1.76 1.87 1.68 2.24 2.44
P/S ratio
1.97 2.77 3.05 2.69 2.91 3.17 3.10 3.35 2.79 2.35
Altman Z″-Score (non-manufacturers)
2.29 2.24 2.49 2.22 2.21 2.09 1.89 1.64 4.61 2.95
P/FCF ratio
16.14 17.93 27.91 33.93 19.01 23.47 22.56 27.18 18.48 15.71
P/Operating CF
23.27 47.46 44.57 52.24 66.29 57.89 39.04 41.00 29.92 41.59
Beneish M-Score
(2.64) (2.57) (2.43) (2.59) (2.73) (2.60) (2.67) (1.95) (2.72) (2.80)
Dividend Safety Score
67 — — — — — — — — —
P/B ratio
1.70 2.16 2.29 2.01 2.35 2.14 2.54 2.55 2.60 3.84
EV/Sales
2.74 3.55 3.73 3.37 3.68 4.05 4.11 4.45 3.16 3.04
EV/EBITDA
11.89 15.28 16.44 14.08 15.72 21.53 17.69 20.42 14.62 14.92
EV/FCF
22.44 22.94 34.17 42.42 24.03 30.06 29.92 36.14 20.93 20.35
Current Ratio
1.11 1.17 1.31 1.04 1.33 1.54 1.18 1.03 5.58 1.45
Net Debt/EBITDA
3.33 3.34 3.01 2.82 3.28 4.72 4.35 5.06 1.71 3.40
Debt/Equity
0.69 0.69 0.57 0.55 0.72 0.72 0.86 0.90 1.44 1.38
ROE
6.54% 6.60% 5.58% 6.90% 8.44% 3.42% 5.14% 0.94% 10.01% 13.19%
ROA
2.98% 3.10% 2.69% 3.16% 3.71% 1.45% 2.05% 0.35% 3.25% 3.75%
ROIC
3.82% 3.61% 3.38% 3.75% 3.67% 1.50% 2.85% 2.44% 5.46% 5.49%
Return on Tangible Assets
21.14% 20.46% 16.57% 26.63% 24.37% 8.47% 16.23% 2.85% 5.17% 16.63%
Average Days of Receivables
50.04 54.86 47.74 42.38 44.84 54.45 49.50 52.96 52.64 47.31
Earnings Yield
3.90% 3.08% 2.42% 3.32% 3.59% 1.51% 2.00% 0.24% 3.10% 3.33%
Free Cash Flow Yield
6.20% 5.58% 3.58% 2.95% 5.26% 4.26% 4.43% 3.68% 5.41% 6.36%
Free Cash Flow per Share
9.28 10.76 7.39 5.26 10.14 7.77 8.79 7.63 8.33 8.77
Book value per Share
88.27 89.35 90.11 88.71 81.85 85.19 78.09 81.26 59.14 35.89
Free Cash Flow
2,670.00 3,119.00 2,116.00 1,498.00 2,932.00 2,168.00 2,373.00 1,970.00 1,823.00 1,866.00
EV/EBIT
23.24 29.84 34.25 27.83 31.30 71.46 40.34 47.18 25.07 26.55
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026